Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-674P is a pseudogene related to the U6 small nuclear RNA family. Unlike the functional U6 snRNA, which is essential for spliceosomal processing of pre-mRNA[1][3], pseudogenes like RNU6-674P are non-coding genomic fragments that do not produce a functional RNA molecule and have no known regulatory or protein-coding function. Pseudogenes of U6 snRNA are abundant in the vertebrate genome, reflecting evolutionary duplication events and possible genomic backup mechanisms, but these copies generally lack biological activity[5][3]. Key distinction: - RNU6-674P is not a functional snRNA and should not be confused with U6 snRNA, which is highly conserved and critical for spliceosome function and mRNA processing[1][3]. - There are no drugs, disease associations, biomarker roles, or safety concerns attributed to this pseudogene. Summary: RNA, U6 small nuclear 674, pseudogene (RNU6-674P) is a genomic pseudogene with no known function, disease relevance, or therapeutic potential[5]. It is listed correctly in gene databases and is not considered a molecular target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 674, pseudogene (RNU6-674P).